Last reviewed · How we verify

NCT06988748

Diet Education and Postoperative Outcomes in Pediatric Adenotonsillectomy

Not yet recruiting NA Last updated 4 June 2025
What this trial tests

NA trial testing Assigned Interventions (diet training) in Adenotonsillar Hypertrophy in 76 participants. Not yet recruiting.

Timeline
20 June 2025
Primary endpoint
30 September 2025
31 October 2026

Quick facts

Lead sponsorMaltepe University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment76
Start date20 June 2025
Primary completion30 September 2025
Estimated completion31 October 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Maltepe University

Who can join

Under 18, any sex, with Adenotonsillar Hypertrophy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial aims to evaluate the effect of tonsillectomy diet education on postoperative bleeding and pain in children undergoing adenotonsillectomy. Seventy-six pediatric patients will be randomly assigned to either an intervention group, which will receive specific diet education prior to surgery, or a control group receiving standard care. Bleeding and pain will be assessed at 4, 8, and 24 hours, and on the 7th day after surgery using a specialized follow-up form and the Wong-Baker Faces Pain Rating Scale. The study hypothesizes that diet education will reduce postoperative bleeding and pain, improving recovery and quality of life in children.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Adenotonsillar Hypertrophy

Currently open trials in the same condition.

Other Maltepe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06988748.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing